OPM Announces Positive Interim Results of Its Phase 1 Study Evaluating OPM-101 in Healthy Volunteers

Completion of the single-dose administration (SDA) part of the Phase 1 healthy volunteers study of OPM-101 and transition to the multiple-dose escalation administration (MDA)A new mechanism of action normalizing TNF-alpha secretion and targeting chronic inflammatory bowel disease (IBD)Excellent tolerability with no...

Related Keywords

Paris ,France General ,France ,Mathilde Bohin Alban Dufumier ,Jan Hoflack ,Arthur Rouill ,Karine Lignel ,Data Review Committee ,Regulatory News ,Precision Medicine ,Chief Scientific Officer ,Chief Executive Officer ,Oncodesign Precision Medicine ,Alban Dufumier ,